These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6806201)

  • 41. Rejection of tumor cells in vitro: a T-cell-mediated reaction.
    Berczi I; Sehon AH
    Int J Cancer; 1975 Oct; 16(4):665-74. PubMed ID: 1080753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic and biological characterization of a T suppressor cell induced by anti-idiotypic antibody.
    Monroe JG; Gurish M; Dambrauskas J; Slaoui M; Lowy A; Greene MI
    J Immunol; 1985 Sep; 135(3):1589-97. PubMed ID: 3160770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell-mediated cytotoxicity to chemically-induced rat tumours.
    Zöller M; Price MR; Baldwin RW
    Int J Cancer; 1975 Oct; 16(4):593-606. PubMed ID: 170224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity.
    Campbell MJ; Esserman L; Byars NE; Allison AC; Levy R
    J Immunol; 1990 Aug; 145(3):1029-36. PubMed ID: 2373859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The oncogenic potential of three different 7,12-dimethylbenz(a)anthracene transformed C3H/10T1/2 cell clones at various passages and the importance of the mode of immunosuppression.
    Saxholm HJ
    Eur J Cancer (1965); 1979 Apr; 15(4):515-26. PubMed ID: 108108
    [No Abstract]   [Full Text] [Related]  

  • 46. Sendai virus-specific T-cell clones: induction of cytolytic T cells by an anti-idiotypic antibody directed against a helper T-cell clone.
    Ertl HC; Finberg RW
    Proc Natl Acad Sci U S A; 1984 May; 81(9):2850-4. PubMed ID: 6326148
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [In vivo study of antitumor immune responses induced by anti-idiotypic minibody vaccine of ovarian cancer].
    Chang XH; Cui H; Feng J; Yang WL; Li Y; Fu TY
    Ai Zheng; 2004 Jul; 23(7):777-81. PubMed ID: 15248911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing hosts.
    Greene MI; Fujimoto S; Sehon AH
    J Immunol; 1977 Aug; 119(2):757-64. PubMed ID: 69667
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for two factors in sera of tumor-immunized mice which induce specific lymphoid cell-dependent cytotoxicity: IgG2 and a rapidly appearing factor not associated with IgG or IgM.
    Pollack SB; Nelson K
    Int J Cancer; 1975 Aug; 16(2):339-46. PubMed ID: 1150357
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation of growth of malignant cells by anti-idiotypic immunity.
    Schreiber H; Flood PM; Kripke ML; Urban JL
    Haematol Blood Transfus; 1981; 26():368-71. PubMed ID: 6976294
    [No Abstract]   [Full Text] [Related]  

  • 51. The chromosomes of primary 7,12-dimethylbenz(a)anthracene-induced rat sarcomas.
    Mitelman F; Levan G
    Hereditas; 1972; 71(2):325-34. PubMed ID: 4376552
    [No Abstract]   [Full Text] [Related]  

  • 52. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes.
    Schirrmacher V; Bosslet K; Shantz G; Clauer K; Hübsch D
    Int J Cancer; 1979 Feb; 23(2):245-52. PubMed ID: 83969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Murine monoclonal anti-idiotypic antibody as a surrogate antigen for human Her-2/neu.
    Baral R; Sherrat A; Das R; Foon KA; Bhattacharya-Chatterjee M
    Int J Cancer; 2001 Apr; 92(1):88-95. PubMed ID: 11279611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of CD4(+) and CD8(+) Bordetella pertussis toxin subunit S1 specific T cells by immunization with synthetic peptides.
    Fagerberg J; Askelöf P; Wigzell H; Mellstedt H
    Cell Immunol; 1999 Sep; 196(2):110-21. PubMed ID: 10527563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monoclonal anti-idiotype antibody bearing the internal image of nasopharyngeal carcinoma associated antigen.
    Li G; Hu J; Zhou G; Zhu J; Sun Q
    Chin Med J (Engl); 2001 Sep; 114(9):962-6. PubMed ID: 11780392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunity to chemically induced rat sarcomas: study of the specificity of cytotoxic cells.
    Goguel AF; Nauciel C
    Ann Immunol (Paris); 1979; 130C(5):621-34. PubMed ID: 316679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-tumor immunity in B-lymphocyte-deprived mice. III. Immunity to primary Moloney sarcoma virus-induced tumors.
    Gordon J; Holden HT; Segal S; Feldman M
    Int J Cancer; 1982 Mar; 29(3):351-7. PubMed ID: 6978293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of cellular immune responses by a murine monoclonal anti-idiotypic antibody recognizing the 791Tgp72 antigen expressed on colorectal, gastric and ovarian human tumours.
    Durrant LG; Doran M; Austin EB; Robins RA
    Int J Cancer; 1995 Mar; 61(1):62-6. PubMed ID: 7705934
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Production of antiidiotypic antibodies in the rat: in vitro characterization of specificity and correlation with in vivo specific suppression of cardiac allograft immune reaction across major histocompatibility complex.
    Wasfie T; Reed E; Suciu-Foca N; Hardy MA
    Surgery; 1990 Aug; 108(2):431-40; discussion 440-1. PubMed ID: 2143319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of specific immune unresponsiveness with purified mixed leukocyte culture-activated T lymphoblasts as autoimmunogen. II. An analysis of the effects measured at the cellular and serological levels.
    Aguet M; Andersson LC; Andersson R; Wight E; Binz H; Wigzell H
    J Exp Med; 1978 Jan; 147(1):50-61. PubMed ID: 75235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.